Merynova Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 98.77%
- Profit Growth -46.87%
- Ebitda 112.24%
- Net Worth 54.72%
- Total Assets 556.85%
About Merynova Life Sciences India
Merynova Life Sciences India Private Limited (MLSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 October 2019 (Five years and four months 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Balu Suram and Naga Kommuri serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TG2019PTC136315
- Company No.
136315
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Merynova Life Sciences India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balu Suram  | Director | 24-Oct-2019 | Current |
| Naga Kommuri | Director | 24-Oct-2019 | Current |
Financial Performance of Merynova Life Sciences India.
Merynova Life Sciences India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.77% increase. The company also saw a substantial fall in profitability, with a 46.87% decrease in profit. The company's net worth Soared by an impressive increase of 54.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Merynova Life Sciences India?
Unlock access to Merynova Life Sciences India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Merynova Lifesciences International Private LimitedBalu Suram and Naga Kommuri are mutual person
- Medjoy Pharmacy Private Limited
Naga Kommuri is a mutual person
- Myren Life Science India Private Limited
Naga Kommuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Merynova Life Sciences India?
Merynova Life Sciences India has a workforce of 56 employees as of Jan 15, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Merynova Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merynova Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.